About Clinical Research
Study #54023-B
Are You a Good Fit?
Male or Female
In general good health
18 years of age and older
Smokers and Non-smokers
Must have had a confirmed case of COVID-19 at least 28 days prior
Never received a COVID-19 vaccine (Naïve)
- Receive up to $1,145 upon completion of this Clinical Research Study for your participation in this study
What are the Time Requirements?
Group 20
Visit DatesHow Much: $1,145
Group 21
Visit DatesHow Much: $1,145
Group 22
Visit DatesHow Much: $1,145
BMI Calculator
Referral Program
Do not forget our REFERRAL PROGRAM. Earn at least $200 for every new participant you refer who completes a study.*
*No referral bonuses are paid out for outpatient vaccine studies.All study dates are tentative and subject to change.
• Eligible individuals must willing and able to comply with all scheduled visits, investigational plan, laboratory tests, lifestyle considerations, and other study procedures.
• Healthy participants are determined by medical history, physical examination, and clinical judgment of the investigator to be eligible for the study.
• Eligible individuals must be capable of giving signed informed consent as described in the protocol, which includes compliance with the requirements and restrictions.
• A female participant is eligible to participate if she is not pregnant or breastfeeding and at least 1 of the following conditions applies:
• Postmenopausal females are defined as no menses for 12 months without an alternative medical cause.
• Is not a WOCBP
• Premenopausal female with 1 of the following:
• Documented hysterectomy;
• Documented bilateral salpingectomy;
• Documented bilateral oophorectomy.
For individuals with permanent infertility due to a medical cause other than the above (eg, mullerian agenesis, androgen insensitivity), investigator discretion should be applied to determining study entry.
• Is a woman of Child Bearing Potential
• Highly Effective Methods That Have Low User Dependency:
• Implantable progestogen only hormone contraception associated with inhibition of ovulation.
• Intrauterine device.
• Intrauterine hormone releasing system.
• Bilateral tubal occlusion.
• Vasectomized partner:
• Vasectomized partner is a highly effective contraceptive method provided that the partner is the sole sexual partner of the WOCBP and the absence of sperm has been confirmed.
If not, an additional highly effective method of contraception should be used. The spermatogenesis cycle is approximately 90 days.
• Highly Effective Methods That Are User Dependent:
• Combined (estrogen and progestogen containing) hormonal contraception associated with inhibition of ovulation:
• Oral;
• Intravaginal;
• Transdermal.
• Progestogen only hormone contraception associated with inhibition of ovulation:
• Oral
• Injectable
• Sexual abstinence is considered a highly effective method only if defined as refraining from heterosexual intercourse during the entire period of risk associated with the study
intervention. The reliability of sexual abstinence needs to be evaluated in relation to the duration of the study and the preferred and usual lifestyle of the participant.
• Other Effective Methods
• Progestogen only oral hormonal contraception where inhibition of ovulation is not the primary mode of action.
• Male or female condom, with or without spermicide.
• Cervical cap, diaphragm, or sponge with spermicide.
• A combination of male condom with either cervical cap, diaphragm, or sponge with spermicide (double barrier methods
If you have previously submitted an application, call 417-831-2048 to enroll. Or click on the button below to submit your application now.